Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study-Reference-Cited by-同舟云学术

Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study

Published:2020-12-29 Issue:5 Volume:87 Page:2290-2302
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit Jnl Clinical Pharma

Author:

Diemen Marcus P.J.¹^ORCID,Hart Ellen P.¹,Abbruscato Anthony²,Mead Liz²,Beelen Ilse¹,Bergheanu Sandrin C.²,Hameeteman Pieter W.¹,Coppen Emma³,Winder Jessica Y.³,Moerland Matthijs¹,Kan Hermien⁴^ORCID,Grond Jeroen⁵,Webb Andrew⁴,Roos Raymund A.C.³,Groeneveld Geert Jan¹

Affiliation:

1. Centre for Human Drug Research Leiden The Netherlands

2. Stealth BioTherapeutics Inc Newton Massachusetts USA

3. Department of Neurology Leiden University Medical Center Leiden The Netherlands

4. Gorter Centre for high‐field MRI Leiden University Medical Center Leiden The Netherlands

5. Radiology Research Center, Department of Radiology Leiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14656